| Successful treatment with tacrolimus of refractory adult-onset Still's disease |
|
Ohe, Masashi
(Department of General Medicine, Hokkaido Social Insurance Hospital)
Oku, Kenji (Department of Medicine II, Hokkaido University Graduate School of Medicine) Kono, Michihito (Department of Medicine II, Hokkaido University Graduate School of Medicine) Bohgaki, Toshiyuki (Department of Medicine II, Hokkaido University Graduate School of Medicine) |
| 1 | Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992;19:424-430. |
| 2 | Yoshida Y, Sakamoto M, Yokota K, Sato K, Mimura T. Tocilizumab improved both clinical and laboratory manifestations except for interleukin-18 in a case of multiple drug-resistant adult-onset Still's disease. Intern Med 2011;50:1757-1760. DOI |
| 3 | Kawaguchi Y, Terajima H, Harigai M, Hara M, Kamatani N. Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still's disease. Arthritis Rheum 2001;44:1716-1717. DOI ScienceOn |
| 4 | Kuinose M, Iwagaki H, Morimoto Y, et al. Calcineurin antagonists inhibit interferon-gamma production by downregulation of interleukin-18 in human mixed lymphocyte reactions. Acta Med Okayama 2000;54:201-209. |
| 5 | Murakami K, Fujii T, Yukawa N, et al. Successful treatment of a patient with refractory adult Still's disease by tacrolimus. Mod Rheumatol 2007;17:167-170. DOI |
 |
Korea Institute of Science and Technology Information
Gwahangno, Yuseong-gu, Daejeon, 305-806, Korea TEL : +82-42-869-1752
Copyright (c) 2009 KISTI. All Rights Reserved. For more information mail to
webmaster
